Pricing Log in Create free account

C4 Therapeutics, Inc. (CCCC) vs Rezolute, Inc. (RZLT)

C4 Therapeutics, Inc. and Rezolute, Inc. are both Biotechnology companies. C4 Therapeutics, Inc. and Rezolute, Inc. are of similar size ($362.9M and $352.1M). Rezolute, Inc. has the higher net margin (0.00% vs −282.2%) and the higher return on invested capital (0.00% vs −280.0%). Across the 13 metrics below, Rezolute, Inc. leads on 9 and C4 Therapeutics, Inc. on 4.

Valuation

Metric CCCC RZLT Biotechnology median
P/E n/m n/m 10.60
P/S 13.15 n/m 9.40
P/B 1.86 3.97 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 7.38 n/m 9.02
Earnings yield (23.08%) (19.74%) (32.88%)
Free cash flow yield (18.88%) (16.35%) (23.13%)

Profitability

Metric CCCC RZLT Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin (315.86%) 0.00% 0.00%
Net margin (282.22%) 0.00% 0.00%
Free cash flow margin (246.71%) 0.00% 0.00%
Return on equity (47.62%) (59.04%) (51.96%)
Return on assets (30.50%) (53.82%) (46.06%)
Return on invested capital (279.99%) 0.00% 0.00%

Growth

Metric CCCC RZLT Biotechnology median
Revenue growth (TTM) 7.20% — 6.76%
EPS growth (last fiscal year) 16.45% 23.47% 29.88%
Revenue growth, 5-year CAGR 1.61% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CCCC RZLT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.17 9.68 4.97
Net debt to EBITDA 2.14 1.26 1.01

Dividend

Metric CCCC RZLT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CCCC RZLT Biotechnology median
Market cap 362.93m 352.10m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack